Total Payments
$10,227
2024 Payments
$78.38
Companies
36
Transactions
514
Medicare Patients
2,529
Medicare Billing
$308,543
Payment Breakdown by Category
Food & Beverage$10,180 (99.5%)
Education$47.30 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,180 | 510 | 99.5% |
| Education | $47.30 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,027 | 106 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,557 | 105 | $0 (2023) |
| Janssen Biotech, Inc. | $956.13 | 43 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $904.01 | 50 | $0 (2017) |
| Ironwood Pharmaceuticals, Inc | $768.19 | 20 | $0 (2022) |
| Boston Scientific Corporation | $549.45 | 15 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $439.40 | 25 | $0 (2023) |
| Gilead Sciences, Inc. | $333.43 | 17 | $0 (2022) |
| Allergan, Inc. | $329.48 | 13 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $328.75 | 19 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $78.38 | 1 | Olympus America Inc. ($78.38) |
| 2023 | $498.14 | 20 | Ardelyx, Inc. ($190.26) |
| 2022 | $1,377 | 62 | ABBVIE INC. ($353.66) |
| 2021 | $745.51 | 47 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($205.96) |
| 2020 | $720.16 | 37 | AbbVie Inc. ($181.08) |
| 2019 | $1,637 | 83 | AbbVie, Inc. ($531.04) |
| 2018 | $2,924 | 143 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($731.46) |
| 2017 | $2,248 | 121 | Valeant Pharmaceuticals North America LLC ($904.01) |
All Payment Transactions
514 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/08/2024 | Olympus America Inc. | HANAROSTENT Esophagus TTS(CCC) (Device) | Food and Beverage | In-kind items and services | $78.38 | General |
| Category: Endotherapy | ||||||
| 05/17/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Gastroenterology | ||||||
| 04/20/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Gastroenterology | ||||||
| 03/22/2023 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/21/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: Immunology | ||||||
| 03/15/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Gastroenterology | ||||||
| 03/14/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Gastroenterology | ||||||
| 03/13/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $3.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/11/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: IMMUNOLOGY | ||||||
| 03/08/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $145.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/08/2023 | Boston Scientific Corporation | Resolution 360 Clip (Device) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Resolution 360 Clip_ENDO | ||||||
| 03/04/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Immunology | ||||||
| 03/01/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/16/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Gastroenterology | ||||||
| 02/15/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/28/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Immunology | ||||||
| 01/25/2023 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/20/2023 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/19/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: IMMUNOLOGY | ||||||
| 01/12/2023 | RedHill Biopharma Inc. | Talicia (Drug), Movantik, Aemcolo | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Antibiotic | ||||||
| 01/11/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/22/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: Gastroenterology | ||||||
| 12/22/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.03 | General |
| Category: Gastroenterology | ||||||
| 12/15/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Gastroenterology | ||||||
| 12/09/2022 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 205 | 209 | $107,705 | $18,802 |
| 2022 | 10 | 750 | 910 | $449,542 | $94,605 |
| 2021 | 12 | 857 | 1,004 | $535,828 | $113,006 |
| 2020 | 13 | 717 | 854 | $402,849 | $82,130 |
Total Patients
2,529
Total Services
2,977
Medicare Billing
$308,543
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 93 | 97 | $32,689 | $6,113 | 18.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 19 | 19 | $23,750 | $3,937 | 16.6% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2023 | 15 | 15 | $14,925 | $2,779 | 18.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 11 | 11 | $12,397 | $2,649 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 45 | $10,260 | $1,957 | 19.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $13,684 | $1,367 | 10.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 246 | 349 | $117,613 | $34,557 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 142 | 195 | $44,460 | $13,178 | 29.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 47 | 48 | $54,096 | $10,795 | 20.0% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2022 | 51 | 51 | $50,745 | $8,058 | 15.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 38 | 38 | $47,500 | $8,031 | 16.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 110 | 111 | $69,042 | $7,821 | 11.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $30,016 | $6,020 | 20.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 28 | 28 | $9,744 | $2,378 | 24.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 21 | 22 | $20,878 | $2,320 | 11.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 12 | $5,448 | $1,446 | 26.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 287 | 404 | $136,148 | $41,137 | 30.2% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 64 | 64 | $72,128 | $13,960 | 19.4% |
| 45384 | Removal of tissue abnormalities, tumors, or polyps of large bowel by hot biopsy forceps, using a flexible endoscope | Facility | 2021 | 83 | 84 | $83,580 | $11,552 | 13.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 90 | 90 | $48,240 | $11,459 | 23.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 99 | 125 | $28,500 | $8,986 | 31.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 111 | 113 | $70,286 | $8,496 | 12.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 25 | 25 | $31,250 | $5,378 | 17.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 20 | 20 | $13,260 | $3,778 | 28.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2021 | 12 | 12 | $15,000 | $2,592 | 17.3% |
About Dr. Robert Goldberg, MD
Dr. Robert Goldberg, MD is a Gastroenterology healthcare provider based in Miami Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134169196.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Goldberg, MD has received a total of $10,227 in payments from pharmaceutical and medical device companies, with $78.38 received in 2024. These payments were reported across 514 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($10,180).
As a Medicare-enrolled provider, Goldberg has provided services to 2,529 Medicare beneficiaries, totaling 2,977 services with total Medicare billing of $308,543. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Miami Beach, FL
- Active Since 06/07/2006
- Last Updated 05/19/2022
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1134169196
Products in Payments
- XIFAXAN (Drug) $1,064
- STELARA (Biological) $1,025
- LINZESS (Drug) $703.07
- XIFAXANIBSD (Drug) $529.63
- Humira (Biological) $466.03
- Creon (Drug) $423.79
- GATTEX (Drug) $336.92
- RELISTOR (Drug) $287.65
- Entyvio (Biological) $281.91
- Talicia (Drug) $266.24
- MOVIPREP (Drug) $253.31
- Mavyret (Drug) $229.59
- CREON (Drug) $227.95
- Linzess (Drug) $225.88
- IBSRELA (Drug) $211.31
- APRISO (Drug) $191.81
- Trulance (Drug) $180.21
- DUPIXENT (Biological) $179.64
- ZENPEP (Drug) $154.62
- TASIGNA (Drug) $141.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Miami Beach
Hernando Gonzalez Quiros, M.d, M.D
Gastroenterology — Payments: $29,855
Gastroenterology $29,855
Dr. Isaac Bassan, M.d, M.D
Gastroenterology — Payments: $16,493
Gastroenterology $16,493
Dr. Jonathan Mazurek, M.d, M.D
Gastroenterology — Payments: $14,893
Gastroenterology $14,893
Frank Czul Gurdian, M.d, M.D
Gastroenterology — Payments: $13,124
Gastroenterology $13,124
Manuel Berzosa Corella, M.d, M.D
Gastroenterology — Payments: $12,307
Gastroenterology $12,307
Dr. Michael Bloom, M.d, M.D
Gastroenterology — Payments: $9,277
Gastroenterology $9,277